Gilead Sciences logo

Director, Business Strategy and Operations

Gilead Sciences

El Segundo, CA; Foster City, CA; Santa Monica, CA; Thousand Oaks, CAHybridPosted 46 days ago$205,615.00 - $266,090.00
Full TimeDirector & AboveCorporate FunctionsPharmaceutical
Original posting ↗

Summary

The Director, Business Strategy & Operations reports to the Vice President and General Manager, US Commercial, and serves as a strategic and operational partner focused on improving organizational effectiveness and business impact. The role leads business strategy, planning, operating cadence, executive decision support, and organizational effectiveness, partnering across US Commercial to translate priorities into coordinated action and measurable outcomes.

Job description

Key Responsibilities

  • Serve as a trusted advisor to the General Manager (GM), synthesizing complex information into executive-ready insights, recommendations, decision materials, and Board-level communications.
  • Translate strategy into priorities, roadmaps, performance measures, operating rhythms, and actionable plans, driving strategic initiatives from development through execution.
  • Lead annual strategic, financial, resource, and headcount planning, including coordination of the consolidated Plan of Action.
  • Design and manage leadership governance, planning cycles, quarterly business reviews, and accountability mechanisms that enable timely decisions and disciplined execution.
  • Coordinate enterprise and functional initiatives across US Commercial, aligning ownership, resources, dependencies, risks, sequencing, and measures of success.
  • Represent US Commercial in enterprise and global planning forums, shaping broader decisions and translating enterprise direction into clear commitments for the US business.
  • Track business performance and commitments, identify barriers, and drive mitigation, course correction, productivity, and process improvements.
  • Lead planning and execution for major GM-sponsored meetings, including National and Midyear Meetings.
  • Partner with commercial leadership to coordinate cross-functional readiness for anticipated US product launches.
  • Advance organizational and leadership effectiveness by improving how the organization operates, collaborates, communicates, and makes decisions.
  • Develop high-impact communications for leadership meetings, business reviews, all-hands presentations, and internal and external audiences.
  • Serve on the Kite Commercial BS&O Forum, ensuring alignment between Commercial Strategy & Operations priorities and US Commercial planning and execution.

Basic Qualifications

  • Advanced scientific degree (i.e., MD, PharmD, PhD) and 8+ years of experience OR Master’s Degree and 10+ years of experience OR Bachelor’s Degree and 12+ years of experience

Preferred Qualifications

  • Significant pharmaceutical or biopharmaceutical experience leading complex strategic and operational initiatives; experience in commercial, finance, or consulting is preferred.
  • Ability to translate enterprise strategy into practical plans and deliver results with rigor, accountability, and attention to detail.
  • Strong executive presence, judgment, communication, and stakeholder-influence skills, including the ability to lead without direct authority.
  • Demonstrated enterprise mindset and ability to navigate ambiguity, connect cross-functional priorities, and manage competing trade-offs.
  • Experience with business planning, financial and resource analysis, project management, and product profit-and-loss considerations.
  • Proactive, adaptable, and resourceful, with strong emotional intelligence, curiosity, and a continuous-improvement mindset.
  • Demonstrated experience driving organizational transformation and operating model effectiveness, including leading change management and adoption across complex, matrixed environments.

Requirements

  • Advanced scientific degree (i.e., MD, PharmD, PhD) and 8+ years of experience OR Master’s Degree and 10+ years of experience OR Bachelor’s Degree and 12+ years of experience
  • Significant pharmaceutical or biopharmaceutical experience leading complex strategic and operational initiatives; experience in commercial, finance, or consulting is preferred.
  • Ability to translate enterprise strategy into practical plans and deliver results with rigor, accountability, and attention to detail.
  • Strong executive presence, judgment, communication, and stakeholder-influence skills, including the ability to lead without direct authority.
  • Demonstrated enterprise mindset and ability to navigate ambiguity, connect cross-functional priorities, and manage competing trade-offs.
  • Experience with business planning, financial and resource analysis, project management, and product profit-and-loss considerations.
  • Proactive, adaptable, and resourceful, with strong emotional intelligence, curiosity, and a continuous-improvement mindset.
  • Demonstrated experience driving organizational transformation and operating model effectiveness, including leading change management and adoption across complex, matrixed environments.

Benefits

  • Medical, Dental & Vision
  • Life Insurance
  • Paid Time Off
  • Annual Bonus
  • Stock-Based Long-Term Incentives

Company overview

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.